secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001213900-24-098068
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q3 2024 revenue doubles to $8.8M; net income of $0.07 per diluted share
--------------------------------------------------------------------------------

- Revenue $8.8M (+127% YoY); net income $1.2M vs net loss $1.5M in Q3 2023.
- Shipped 27 systems (11 in Q3 2023); cash $22.6M, no debt.
- Adjusted EBITDA $1.6M (negative $1.7M a year ago).
- Signed Fair Deal Agreement with Platinum Dermatology (130+ clinics); 22 agreements since March 2024.
- Sold SRT system to Providence Swedish Hospital; expects recurring revenue from Fair Deal Agreements in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024098068/0001213900-24-098068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024098068/ea0221149-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-098068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer